Privia Health Group, Inc. $PRVA Shares Sold by Voya Investment Management LLC

Voya Investment Management LLC decreased its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 11.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 187,826 shares of the company’s stock after selling 24,516 shares during the quarter. Voya Investment Management LLC owned 0.15% of Privia Health Group worth $4,217,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in PRVA. Van Berkom & Associates Inc. acquired a new stake in Privia Health Group in the first quarter valued at approximately $45,207,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Privia Health Group by 180.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,633,040 shares of the company’s stock worth $59,112,000 after purchasing an additional 1,693,870 shares in the last quarter. Nuveen LLC acquired a new stake in Privia Health Group during the first quarter worth approximately $26,899,000. Royce & Associates LP acquired a new stake in Privia Health Group during the first quarter worth approximately $6,818,000. Finally, Two Sigma Investments LP raised its holdings in Privia Health Group by 153.9% during the fourth quarter. Two Sigma Investments LP now owns 219,839 shares of the company’s stock worth $4,298,000 after purchasing an additional 133,239 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $22.37 on Friday. The firm’s fifty day moving average price is $21.24 and its 200 day moving average price is $22.45. Privia Health Group, Inc. has a 1-year low of $16.47 and a 1-year high of $26.09. The firm has a market cap of $2.75 billion, a price-to-earnings ratio of 203.38, a price-to-earnings-growth ratio of 3.28 and a beta of 0.82.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The firm had revenue of $521.15 million during the quarter, compared to analysts’ expectations of $466.97 million. During the same quarter last year, the business earned $0.19 earnings per share. The business’s quarterly revenue was up 23.4% on a year-over-year basis. Privia Health Group has set its FY 2025 guidance at EPS. As a group, analysts expect that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on PRVA shares. Stephens reissued an “overweight” rating and set a $32.00 price objective on shares of Privia Health Group in a report on Thursday, September 4th. Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th. Evercore ISI cut their price objective on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating on the stock in a report on Wednesday, July 9th. JPMorgan Chase & Co. raised their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an “overweight” rating in a report on Wednesday, May 28th. Finally, JMP Securities raised their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, August 29th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, Privia Health Group presently has an average rating of “Moderate Buy” and a consensus price target of $28.58.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.